The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.

The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.

<h4>Background</h4>Studies have shown that early ART initiation in TB/HIV co-infected patients lowers mortality. One way to implement earlier ART commencement could be through integration of TB and HIV services, a more efficient model of care than separate, vertical programs. We present...

Full description

Bibliographic Details
Main Authors:	Bernhard Kerschberger, Katherine Hilderbrand, Andrew M Boulle, David Coetzee, Eric Goemaere, Virginia De Azevedo, Gilles Van Cutsem
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23071690/pdf/?tool=EBI

Similar Items

Khayelitsha 2001 - 2011: 10 years of primary care HIV and TB programmes
by: Daniela Belen Garone, et al.
Published: (2011-12-01)

Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.
by: Gilles Van Cutsem, et al.
Published: (2011-01-01)

Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
by: Helen S Cox, et al.
Published: (2010-01-01)

Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa.
by: Miguel Angel Luque-Fernandez, et al.
Published: (2013-01-01)

Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa
by: Hernan, Miguel Angel, et al.
Published: (2013)

Reflections on a decade of delivering PMTCT in Khayelitsha, South Africa
by: Kathryn Stinson, et al.
Published: (2014-02-01)

High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: A model of care in Khayelitsha, South Africa
by: D B Garone, et al.
Published: (2013-11-01)

Reply to “At the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection”
by: Valeria Saraceni, et al.
Published: (2014-09-01)

Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
by: Damani A. Piggott, et al.
Published: (2011-01-01)

Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients.
by: Dominique J Pepper, et al.
Published: (2012-01-01)

Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
by: Hannock Tweya, et al.
Published: (2018-01-01)

Effect of antiretroviral therapy on survival of HIV/TB-infected patients in Ukraine
by: Mykhailo Andreychyn, et al.
Published: (2013-04-01)

Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa.
by: Kathryn M Chu, et al.
Published: (2010-02-01)

HIV testing and antiretroviral therapy initiation at birth: Views from a primary care setting in Khayelitsha
by: Aurélie Nelson, et al.
Published: (2015-04-01)

Mortality and loss to follow up before initiation of antiretroviral therapy among HIV-infected children eligible for HIV treatment
by: Gerardo Alvarez-Uria, et al.
Published: (2014-05-01)

Late mortality, loss to follow-up, and associated factors in adults on long term antiretroviral therapy in Khayelitsha
by: Van Cutsem, Gilles
Published: (2015)

Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.
by: Neeraj Raizada, et al.
Published: (2009-06-01)

Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho.
by: Helen Bygrave, et al.
Published: (2011-01-01)

Timeliness of antiretroviral therapy initiation in the era before universal treatment
by: Nikolina Bogdanić, et al.
Published: (2021-05-01)

How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 909090 target in the population on antiretroviral treatment in Khayelitsha South Africa
by: J Euvrard, et al.
Published: (2019-02-01)

Trends in loss to follow-up among migrant workers on antiretroviral therapy in a community cohort in Lesotho.
by: Helen Bygrave, et al.
Published: (2010-01-01)

The impact of isoniazid preventative therapy and antiretroviral therapy on tuberculosis (TB) in HIV-infected children in a high TB incidence setting
by: Frigati, Lisa Jane
Published: (2014)

Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil.
by: Fernanda O Demitto, et al.
Published: (2019-01-01)

HIV-TB coinfection: Clinico-epidemiological determinants at an antiretroviral therapy center in Southern India
by: Ramachandra Kamath, et al.
Published: (2013-01-01)

Efficacy of antituberculosis therapy in combination with antiretroviral therapy in patients with co-infection TB/HIV
by: Kryzhanovsky D.G., et al.
Published: (2013-03-01)

Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy
by: Shruthi Ravimohan, et al.
Published: (2016-01-01)

Cell-associated HIV-1 DNA and viral load evaluation in HIV-1 infected children before and after combination antiretroviral therapy initiation
by: M. Moragas, et al.
Published: (2015-12-01)

Bundling HIV and TB Care at a District-Level Center in Sierra Leone: A high-yield method for diagnosing co-infection with TB and antiretroviral treatment failure among people living with HIV
by: Asa Oxner, et al.
Published: (2019-05-01)

The effeciveness and determinants of effectiveness of antiretroviral therapy for adults in the Western Cape Province, South Africa
by: Boulle, Andrew
Published: (2014)

Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
by: Samantha R Kaplan, et al.
Published: (2017-11-01)

CD4 LYMPHOCYTE IN HIV / AIDS BEFORE AND AFTER ANTIRETROVIRAL THERAPY
by: Rangsang Bagus Prabowo, et al.
Published: (2017-10-01)

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
by: Petros Isaakidis, et al.
Published: (2012-01-01)

Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.
by: Anne F Rositch, et al.
Published: (2013-01-01)

Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.
by: Vlada V Melekhin, et al.
Published: (2009-09-01)

HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
by: A. V. Mordyk, et al.
Published: (2016-06-01)

A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa
by: Helena Huerga, et al.
Published: (2017-09-01)

Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection.
by: Masahiko Mori, et al.
Published: (2015-01-01)

Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
by: Mhairi Maskew, et al.
Published: (2013-01-01)

Coordinated In Vitro Release of Granulysin, Perforin and IFN-γ in TB and HIV/TB Co-Infection Associated with Clinical Outcomes before and after Anti-TB Treatment
by: Nada Pitabut, et al.
Published: (2020-08-01)

Perceived adherence barriers among patients failing second-line antiretroviral therapy in Khayelitsha, South Africa
by: W Barnett, et al.
Published: (2013-11-01)